OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Metabolizing status of CYP2C19 in response and side effects to medications for depression: Results from a naturalistic study
Marco Calabrò, Chiara Fabbri, Siegfried Kasper, et al.
European Neuropsychopharmacology (2022) Vol. 56, pp. 100-111
Closed Access | Times Cited: 14
Marco Calabrò, Chiara Fabbri, Siegfried Kasper, et al.
European Neuropsychopharmacology (2022) Vol. 56, pp. 100-111
Closed Access | Times Cited: 14
Showing 14 citing articles:
Metabolic activity of CYP2C19 and CYP2D6 on antidepressant response from 13 clinical studies using genotype imputation: a meta-analysis
Danyang Li, Oliver Pain, Chiara Fabbri, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Danyang Li, Oliver Pain, Chiara Fabbri, et al.
Translational Psychiatry (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
A machine learning approach to predict treatment efficacy and adverse effects in major depression using CYP2C19 and clinical-environmental predictors
Marco Calabrò, Chiara Fabbri, Alessandro Serretti, et al.
Psychiatric Genetics (2025)
Closed Access
Marco Calabrò, Chiara Fabbri, Alessandro Serretti, et al.
Psychiatric Genetics (2025)
Closed Access
CYP2C19 slow metabolizer phenotype is associated with lower antidepressant efficacy and tolerability
Danilo Joković, F. Milosavljević, Zvezdana Stojanović, et al.
Psychiatry Research (2022) Vol. 312, pp. 114535-114535
Open Access | Times Cited: 15
Danilo Joković, F. Milosavljević, Zvezdana Stojanović, et al.
Psychiatry Research (2022) Vol. 312, pp. 114535-114535
Open Access | Times Cited: 15
Identifying genetic variants associated with side effects of antidepressant treatment: A systematic review
Gabriel Zurchimitten, Laísa Camerini, Geison Souza Izídio, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2024) Vol. 136, pp. 111154-111154
Closed Access | Times Cited: 2
Gabriel Zurchimitten, Laísa Camerini, Geison Souza Izídio, et al.
Progress in Neuro-Psychopharmacology and Biological Psychiatry (2024) Vol. 136, pp. 111154-111154
Closed Access | Times Cited: 2
An Overview of Pharmacogenomic Testing for Psychiatric Disorders
Calvin Young, Danielle MacDougall
Canadian Journal of Health Technologies (2023) Vol. 3, Iss. 6
Open Access | Times Cited: 6
Calvin Young, Danielle MacDougall
Canadian Journal of Health Technologies (2023) Vol. 3, Iss. 6
Open Access | Times Cited: 6
CYP2C19 Genetic Variants and Major Depressive Disorder: A Systematic Review
Larissa Sousa Silva Bonasser, Calliandra Maria de Souza Silva, Caroline Ferreira Fratelli, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 11, pp. 1461-1461
Open Access | Times Cited: 2
Larissa Sousa Silva Bonasser, Calliandra Maria de Souza Silva, Caroline Ferreira Fratelli, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 11, pp. 1461-1461
Open Access | Times Cited: 2
Pharmacokinetic Markers of Clinical Outcomes in Severe Mental Illness: A Systematic Review
Pasquale Paribello, Mirko Manchia, Federica Pinna, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4776-4776
Open Access | Times Cited: 5
Pasquale Paribello, Mirko Manchia, Federica Pinna, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4776-4776
Open Access | Times Cited: 5
Pharmacogenomic and pharmacometabolomic biomarkers of the efficacy and safety of antidepressants: focus on selective serotonin reuptake inhibitors
А. Э. Гареева, Liliya Borodina, S A Pozdnyakov, et al.
S S Korsakov Journal of Neurology and Psychiatry (2024) Vol. 124, Iss. 6, pp. 26-26
Closed Access | Times Cited: 1
А. Э. Гареева, Liliya Borodina, S A Pozdnyakov, et al.
S S Korsakov Journal of Neurology and Psychiatry (2024) Vol. 124, Iss. 6, pp. 26-26
Closed Access | Times Cited: 1
Effect of CYP2C19 Pharmacogenetic Testing on Predicting Citalopram and Escitalopram Tolerability and Efficacy: A Retrospective, Longitudinal Cohort Study
Mahmood Mahajna, Rami Abu Fanne, Matitiahu Berkovitch, et al.
Biomedicines (2023) Vol. 11, Iss. 12, pp. 3245-3245
Open Access | Times Cited: 3
Mahmood Mahajna, Rami Abu Fanne, Matitiahu Berkovitch, et al.
Biomedicines (2023) Vol. 11, Iss. 12, pp. 3245-3245
Open Access | Times Cited: 3
Meta-analysis of CYP2C19 and CYP2D6 metabolic activity on antidepressant response from 13 clinical studies using genotype imputation
Danyang Li, Oliver Pain, Chiara Fabbri, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Danyang Li, Oliver Pain, Chiara Fabbri, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access | Times Cited: 1
Unraveling the Genetic Interplay and Therapeutic Potentials between Major Depressive Disorder and Metabolic Syndrome: Multi-Ancestry and Multi-Trait Genome-Wide Association Analyses
Yu Feng, Ningning Jia, Xiaochu Gu, et al.
Research Square (Research Square) (2024)
Open Access
Yu Feng, Ningning Jia, Xiaochu Gu, et al.
Research Square (Research Square) (2024)
Open Access
Pharmacogenomic and Pharmacometabolomic Biomarkers of the Efficacy and Safety of Antidepressants: Focus on Selective Serotonin Reuptake Inhibitors
А. Э. Гареева, Liliya Borodina, S A Pozdnyakov, et al.
Neuroscience and Behavioral Physiology (2024)
Closed Access
А. Э. Гареева, Liliya Borodina, S A Pozdnyakov, et al.
Neuroscience and Behavioral Physiology (2024)
Closed Access
Impact of CYP2C19 Phenotype on Escitalopram Response in Geriatrics: Based on Physiologically‐Based Pharmacokinetic Modeling and Clinical Observation
Yoo Jin Jang, Doh Kwan Kim, Shinn‐Won Lim, et al.
Clinical Pharmacology & Therapeutics (2024)
Closed Access
Yoo Jin Jang, Doh Kwan Kim, Shinn‐Won Lim, et al.
Clinical Pharmacology & Therapeutics (2024)
Closed Access
PharmGScore scores of compound genetic variant burden for psychiatric treatment optimization
Małgorzata Borczyk, Jacek Hajto, Marcin Piechota, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
Małgorzata Borczyk, Jacek Hajto, Marcin Piechota, et al.
medRxiv (Cold Spring Harbor Laboratory) (2023)
Open Access
